Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-24-000809

President and Head of R&D acquired 863,617 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nagendran Sukumar President and Head of R&D 2024-01-02 Grant or award +863,617 897,843 D
Derivatives
Nagendran Sukumar President and Head of R&D 2024-01-02 Grant or award · Employee Stock Option (right to buy) +863,617 863,617 D
Loading xslF345X05/doc4.xml…